More articles about: Cancer (Oncology)

Michigan Medicine radiation oncology staff help grant wishes and spread joy to pediatric cancer patients at C.S. Mott Children's Hospital.

University of Michigan researchers have created nanodiscs that can target cholesterol levels in GBM, starving the cancer cells and increasing survival rates of the treated mice.

How one woman found 'a beautiful gift' within stage 4 lung cancer.

U-M football fans Jim and Connie Achtenberg are turning their experience with glioblastoma into hope by funding research at Rogel Cancer Center.

Mary Vandewiele's commitment to integrative oncology training programs is a powerful example of how philanthropy advances patient care.

Ethan White was diagnosed with diffuse midline glioma, a rare form of brain cancer where the survival time after diagnosis is 1-2 years. His treatment is going well and Koschmann is cautiously optimistic about his case.

Research by the University of Michigan Health Rogel Cancer Center finds that patients with three of these variants face no extra risk of dying from their cancer.

Researchers at the Rogel Cancer Center, in collaboration with Arcascope, have developed and tested a personalized app that tracks a user’s circadian rhythm and makes behavioral recommendations to reduce daily fatigue.

Despite a devastating diagnosis of glioblastoma, Chris Barry is thankful for her family, friends and the care she’s receiving at Michigan Medicine.

A specialist outlines some recent advances that have him excited for the future of multiple myeloma treatment.

Michigan Medicine experts discuss CAR T therapy, its use in other clinical trials at U-M and the new Phase I trials that started in March 2025.

Avapritinib, an FDA-approved drug used to treat other types of cancer, also decreases aggressive gliomas in animal models and in an initial cohort of patients with high-grade glioma.

Melissa Pilewskie, M.D., answers questions about how you can accurately assess your risk and what lifestyle changes can help reduce the likelihood of developing breast cancer.

A study demonstrates how histotripsy could stimulate the immune system to destroy a cancer through the release of tumor antigens.

Michigan Medicine's College of Pharmacy researchers have developed a promising new weapon in the war on cancer: small circular mRNA vaccines.